Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care.

Abstract:

OBJECTIVE:This study provides insight into the thoughts and opinions of geriatric health-care professionals toward cognitive assessments and the use of emerging technologies, such as eye-tracking, to supplement current tools. METHODS:Two focus group sessions were conducted with nurses and physicians who routinely administer neurocognitive assessments to geriatric populations. Video recordings of the focus group sessions were transcribed and a thematic analysis was performed. RESULTS:Participants reported the need for assessment and diagnostic tools that are accessible and efficient, and that are capable of accommodating the rapid growth in the aging population. The prevalence of more complex ailments experienced by older adults has had repercussions in the quality of care that the clients receive, and has contributed to lengthy wait times and resource shortages. Health-care professionals stated that they are hampered by the disjointed structure of the health-care system and that they would benefit from a more efficient allocation of responsibilities made possible through tools that did not require extensive training or certification. Eyetracking-based cognitive assessments were thought to strongly complement this system, yet it was thought that difficulty would be faced in gaining the support and increased uptake by health-care professionals due to the nonintuitive relationship between eyetracking and cognition. CONCLUSION:The findings suggest that health-care professionals are receptive to the use of eyetracking technology to assess for cognitive health as it would conserve resources by allowing frontline staff to administer assessments with minimal training.

authors

Whitehead JC,Gambino SA,Richter JD,Ryan JD

doi

10.2147/NDT.S82881

subject

Has Abstract

pub_date

2015-06-12 00:00:00

pages

1455-66

eissn

1176-6328

issn

1178-2021

pii

ndt-11-1455

journal_volume

11

pub_type

杂志文章
  • The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.

    abstract:BACKGROUND:Anhedonia constitutes a coherent construct, with neural correlates and negative clinical impact, independent of depression. However, little is known about the neural correlates of anhedonia in stroke patients. In this study, we investigated the association of post-stroke anhedonia with salivary cortisol leve...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S73722

    authors: Terroni L,Amaro E Jr,Iosifescu DV,Mattos P,Yamamoto FI,Tinone G,Conforto AB,Sobreiro MF,Guajardo VD,De Lucia MC,Moreira AC,Scaff M,Leite CC,Fraguas R

    更新日期:2015-02-03 00:00:00

  • Secondary central nervous system lymphoma: spectrum of morphological MRI appearances.

    abstract:Background:Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary central nervous system (CNS) involvement in patients with systemic lymphoma. According to previous reports, SCNSL presents mostly with leptomeningeal spread; however, our experience differs. In t...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S157959

    authors: Malikova H,Burghardtova M,Koubska E,Mandys V,Kozak T,Weichet J

    更新日期:2018-03-12 00:00:00

  • High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.

    abstract:BACKGROUND:Relapse is common in schizophrenia, and seriously impacts patients' quality of life and social functioning. Many factors have been identified that may potentially increase the risk of relapse. This study was designed to investigate the relapse rate in the year following hospital discharge among Chinese patie...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S72367

    authors: Xiao J,Mi W,Li L,Shi Y,Zhang H

    更新日期:2015-05-08 00:00:00

  • Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides.

    abstract:Background:Based on inconsistent sensory alterations demonstrated in cluster headache (CH), the aim of this study was to determine whether patients with CH develop sensory changes in the symptomatic side compared to the asymptomatic side. Methods:Quantitative sensory testing (QST), including pressure pain threshold (P...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S186051

    authors: Malo-Urriés M,Hidalgo-García C,Estébanez-de-Miguel E,Tricás-Moreno JM,Santos-Lasaosa S,Jahanshahi M

    更新日期:2018-12-10 00:00:00

  • Clinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome.

    abstract::Objective: Fibromyalgia syndrome (FMS) is a chronic disorder associated with severe pain. According to the National Fibromyalgia Association, the prevalence of FMS is between 3% and 6% in the general population, with about 90% of the patients being women. The primary goal of this study was to evaluate the relationship...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S198434

    authors: Amin OA,Abouzeid SM,Ali SA,Amin BA,Alswat KA

    更新日期:2019-05-27 00:00:00

  • Aspects of cognitive performance relating to Theory of Mind (ToM) among people diagnosed with Post-Traumatic Stress Disorder (PTSD) [Retraction].

    abstract::[This retracts the article DOI: 10.2147/NDT.S214595.]. ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,撤回出版物

    doi:10.2147/NDT.S227512

    authors:

    更新日期:2019-08-22 00:00:00

  • Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study.

    abstract::Cognitive impairment is closely related to real-life functioning in patients with schizophrenia. The aim of the present study was to evaluate the effects of adjunctive treatment with donepezil on cognition in patients with chronic schizophrenia. This was a 12-week, double-blind, randomized, placebo-controlled study of...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S64189

    authors: Zhu W,Zhang Z,Qi J,Liu F,Chen J,Zhao J,Guo X

    更新日期:2014-07-14 00:00:00

  • Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients.

    abstract:BACKGROUND:Physical exercise has well-characterized positive effects on depressive symptoms. The underlying biologic mechanisms are, however, far from established. A recently discovered mechanism has linked the enhanced conversion of kynurenine to kynurenic acid (KYNA) to an increased resilience toward stress-induced d...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S131746

    authors: Millischer V,Erhardt S,Ekblom Ö,Forsell Y,Lavebratt C

    更新日期:2017-03-31 00:00:00

  • Reproductive life events and Alzheimer's disease in Italian women: a retrospective study.

    abstract::The aim of our study was to understand the complex relationship between the major reproductive life events in women with Alzheimer's disease. In a retrospective, case-control study, 275 women with Alzheimer's disease (AD) and 276 control patients from a hospital population were enrolled from July 2007 to December 2010...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S36622

    authors: Zucchella C,Sinforiani E,Citterio A,Giarracca V,Bono G,Mauri M

    更新日期:2012-01-01 00:00:00

  • Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review.

    abstract::Transcranial magnetic stimulation is an increasingly popular FDA-approved treatment for resistant depression, migraines, and OCD. Research is also underway for its use in various other psychiatric and medical disorders. Although rare, seizures are a potential adverse event of TMS treatment. In this article, we discuss...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S276635

    authors: Stultz DJ,Osburn S,Burns T,Pawlowska-Wajswol S,Walton R

    更新日期:2020-12-07 00:00:00

  • Drug-drug interactions involving antidepressants: focus on desvenlafaxine.

    abstract::Psychiatric and physical conditions often coexist, and there is robust evidence that associates the frequency of depression with single and multiple physical conditions. More than half of patients with depression may have at least one chronic physical condition. Therefore, antidepressants are often used in cotherapy w...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S157708

    authors: Low Y,Setia S,Lima G

    更新日期:2018-02-19 00:00:00

  • Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment.

    abstract:BACKGROUND:The primary objective of this prospective observational study was to evaluate changes in self-reported disability in patients with anxiety or mood disorders 3 months after initiating antidepressant treatment. METHODS:This study included 8396 patients consulting 2433 general practitioners in France for a maj...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S34132

    authors: Gérard A,Liard F,Crochard A,Goni S,Millet B

    更新日期:2012-01-01 00:00:00

  • Biomarkers for depression: recent insights, current challenges and future prospects.

    abstract::A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis. This lack of progress is par...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S114542

    authors: Strawbridge R,Young AH,Cleare AJ

    更新日期:2017-05-10 00:00:00

  • Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study.

    abstract:BACKGROUND:Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHODS:The sample consist...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S39322

    authors: Dell'osso B,Arici C,Dobrea C,Camuri G,Benatti B,Altamura AC

    更新日期:2013-01-01 00:00:00

  • Normal pressure hydrocephalus co-existing with a second dementia disorder.

    abstract::An 87-year-old woman had both Lewy body dementia and normal pressure hydrocephalus simultaneously. One should not automatically exclude the possibility of normal pressure hydrocephalus simply because another neurodegenerative disorder is present, especially if the second disorder masks typical symptoms of normal press...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/ndt.s2027

    authors: Alisky J

    更新日期:2008-02-01 00:00:00

  • New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab.

    abstract::Multiple Sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system, and both T and B cells are involved in its pathogenesis. The vast majority of disease-modifying drugs used for MS act on the inflammatory component of the disease and are approved for use in relapsing-remitting (RR)...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S147874

    authors: Frau J,Coghe G,Lorefice L,Fenu G,Cocco E

    更新日期:2018-04-23 00:00:00

  • The efficacy of a "cocktail therapy" on Parkinson's disease with dementia.

    abstract::Objective: To explore the efficacy and safety of "cocktail therapy" in Parkinson's disease with dementia (PDD). Patients and methods: Sixty patients with PDD were randomly assigned to the test group (n=30) and a control group (n=30). The control group received 10 mg of donepezil hydrochloride tablets orally, once a da...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S179453

    authors: Zhang C,Zang Y,Song Q,Li H,Hu L,Zhao W,Feng S,Gu F,Zhao F,Zhang C

    更新日期:2019-06-24 00:00:00

  • Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM).

    abstract:PURPOSE:Major depressive disorder (MDD) is highly prevalent in patients with a chronic physical condition, and this comorbidity has a negative influence on quality of life, health care costs, self-care, morbidity, and mortality. Research has shown that collaborative care (CC) may be a cost-effective treatment. However,...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S134008

    authors: Goorden M,van der Feltz-Cornelis CM,van Steenbergen-Weijenburg KM,Horn EK,Beekman AT,Hakkaart-van Roijen L

    更新日期:2017-07-18 00:00:00

  • Protective effects of l-glutamine against toxicity of deltamethrin in the cerebral tissue.

    abstract:BACKGROUND:Deltamethrin (DLM) is a broad-spectrum synthetic dibromo-pyrethroid pesticide that is widely used for agricultural and veterinary purposes. However, human exposure to the pesticide leads to neurotoxicity. Glutamine is one of the principal, free intracellular amino acids and may also be an antioxidant. This s...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S104011

    authors: Varol S,Özdemir HH,Çevik MU,Altun Y,Ibiloğlu I,Ekinci A,Ibiloğlu AO,Balduz M,Arslan D,Tekin R,Aktar F,Aluçlu MU

    更新日期:2016-04-21 00:00:00

  • The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors.

    abstract:Objective:Stroke survivors generally have problems completing instrumental activities of daily living (IADL; eg, preparing meals, chores, taking a bath, and managing finances). However, it is unclear how stroke survivors might stave off IADL issues. Studies indicating that sleep has restorative neurological effects pro...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S177527

    authors: Seixas AA,Chung DP,Richards SL,Madhavaram S,Raghavan P,Gago J,Casimir G,Jean-Louis G

    更新日期:2019-01-04 00:00:00

  • Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence.

    abstract::Traumatic brain injury (TBI) remains the main cause of disability and a major public health problem worldwide. This review focuses on the neurophysiology of TBI, and the rationale and current state of evidence of clinical application of brain stimulation to promote TBI recovery, particularly on consciousness, cognitiv...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S65816

    authors: Li S,Zaninotto AL,Neville IS,Paiva WS,Nunn D,Fregni F

    更新日期:2015-06-30 00:00:00

  • Towards an Outpatient Model of Care for Motor Functional Neurological Disorders: A Neuropsychiatric Perspective.

    abstract::Functional neurological disorder (FND), a condition at the intersection of neurology and psychiatry, is a common and disabling outpatient referral to neurology and neuropsychiatry clinics. In this perspective article, we focus on the motor spectrum of FND (mFND), including individuals with functional movement disorder...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S247119

    authors: Saxena A,Godena E,Maggio J,Perez DL

    更新日期:2020-09-18 00:00:00

  • Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy.

    abstract::Tuberous sclerosis complex (TSC) is a relatively rare genetic disorder, affecting one in 6,000 births. Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus, which have been previously used to prevent solid organ transplant rejection, augment anticancer treatment regimens, and prevent neovascularization ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S91248

    authors: Capal JK,Franz DN

    更新日期:2016-08-25 00:00:00

  • Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study.

    abstract::At the time of this study, there were five known patients with Wilson disease (WD) in Iceland. The mutation, a 7-bp deletion in exon 7 on chromosome 13 for WD, is only known in Iceland. In twenty healthy Icelandic heterozygotes for WD and their age- and gender-matched controls, copper concentration in plasma, cerulopl...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s4360

    authors: Tórsdóttir G,Gudmundsson G,Kristinsson J,Snaedal J,Jóhannesson T

    更新日期:2009-01-01 00:00:00

  • Late life bipolar disorder evolving into frontotemporal dementia mimic.

    abstract:OBJECTIVES:Although bipolar disorder has been understood classically as a cyclic disease with full recovery between mood episodes, in the last decade, evidence has accumulated supporting progressive features. The clinical picture of advanced or end-stage bipolar disorder is heterogeneous with possible deficits in cogni...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S99229

    authors: Dols A,Krudop W,Möller C,Shulman K,Sajatovic M,Pijnenburg YA

    更新日期:2016-09-07 00:00:00

  • Suicidal behavior among Turkish patients with Parkinson's disease.

    abstract:OBJECTIVE:To investigate the predictors of suicidal ideation and attempts among Turkish Parkinson's disease (PD) patients. MATERIALS AND METHODS:The study comprised 120 patients with PD. Clinical findings were obtained by using the Unified Parkinson's Disease Rating Scale. Disease severity was measured by the Hoehn an...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S60450

    authors: Ozdilek B,Gultekin BK

    更新日期:2014-03-26 00:00:00

  • Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression.

    abstract::Depression is a major psychiatric disorder. The standard treatment for depression is antidepressant medication, but the responses to antidepressant treatment are only partial, even poor, among 30%-45% of patients. Refractory depression is defined as depression that does not respond to antidepressant therapy after 4 we...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S40466

    authors: Chen SJ,Chang CH,Tsai HC,Chen ST,Lin CCh

    更新日期:2013-01-01 00:00:00

  • Management of migraine in adolescents.

    abstract::Headaches in children and adolescents are still under-diagnosed. 75% of children are affected by primary headache by the age of 15 with 28% fitting the ICHD2 criteria of migraine. Migraine is considered a chronic disorder that can severely impact a child's daily activities, including schooling and socializing. Early r...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s495

    authors: Kabbouche MA,Gilman DK

    更新日期:2008-06-01 00:00:00

  • Bupropion interferes with the image diagnosis of Parkinson's disease.

    abstract::Major depressive disorder (MDD) and Parkinson's disease (PD) share symptoms such as tremor. Bupropion, a norepinephrine-dopamine reuptake inhibitor, shows weak dopamine transporter (DAT) occupancy. We report here on a patient with MDD whose hand tremors might have been misdiagnosed as PD by single-photon emission comp...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S150912

    authors: Lin CH,Lane HY

    更新日期:2017-10-19 00:00:00

  • Disease-modifying therapies in relapsing-remitting multiple sclerosis.

    abstract:CLINICAL QUESTION:What is the best current disease-modifying therapy for relapsing-remitting multiple sclerosis? RESULTS:The evidence shows that the most effective disease-modifying therapy for delaying short- to medium-term disability progression, prevention of relapses, reducing the area and activity of lesions on m...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s11079

    authors: González-Andrade F,Alcaraz-Alvarez JL

    更新日期:2010-09-07 00:00:00